Power Law company profile

Adaptive Biotechnologies

Biotech & Life Sciences · Seattle, United States · Founded 2009 · IPO 2019 Thoroughbred

Translates a scale and precision of the adaptive immune system into products to diagnose and treat disease

Valuation

$2.10B

Market cap · May/2026

Revenue

$277M

Latest reported FY

EBITDA

$2.4M

Latest reported FY

Featured in $10B+ revenueThoroughbred · Power Law outcome

Investors

6 investors on Adaptive Biotechnologies's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series B+ 6 investors entered at this stage

Rock Springs Capital

Foresite Capital

Tiger Management Corporation

Matrix Capital Management

Senator Investment Group

Viking Global Investors

Adaptive Biotechnologies mafia

Startups founded by Adaptive Biotechnologies alumni

Former Adaptive Biotechnologies employees who went on to start their own companies. Sorted by Dealroom signal score.

BlinkEst. 2015

Sean NolanUnited Kingdom

Signal score96

Lumen BioscienceEst. 2017

Brian FinrowUnited States

Signal score86

DuettoEst. 2012

Craig WeissmanUnited States

Signal score85

VinetiEst. 2016

Malek FahamUnited States

Signal score64

Book a demo to explore the full alumni network →

Global footprint

Where Adaptive Biotechnologies has talent and traffic

AI talent share

1.2% of workforce is AI talent
(8 of 659 staff)

Core AI30.46%

Other AI50.76%

Non-AI workforce65198.79%

Workforce by country

7 countries with
team presence

🇺🇸 United States98.7%

🇨🇦 Canada0.6%

🇮🇳 India0.2%

🇦🇷 Argentina0.2%

🇮🇹 Italy0.2%

Top 5 of 7 shown

Web traffic by country

24K monthly visits
across markets

🇺🇸 United States77.1%

🇬🇧 United Kingdom7.1%

🇨🇦 Canada4.6%

🇮🇳 India3.3%

🇯🇵 Japan2.1%

Top 5 markets shown

Market sentiment

What the market is saying about Adaptive Biotechnologies

An AI-synthesized read of the highest-engagement posts about Adaptive Biotechnologies on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Adaptive Biotechnologies on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles